Investors are running into Viking Therapeutics (NASDAQ: VKTX) this week after an incident of drug-induced liver injury pushed Pfizer (NYSE: PFE) into terminating the development of its weight-loss pill.Viking’s share price has gained % in recent sessions on speculation that PFE will now resort to an acquisition to expand its…
European stock markets retreated at the open on Wednesday, snapping a two-day winning streak as persistent uncertainty over US…
Shares of British business supplies group Bunzl fell sharply on Wednesday after the company cut its 2025 forecast and…
Google is facing a major legal challenge in the United Kingdom, where a class action lawsuit has been filed…
Argentina’s currency and bond market reacted sharply as the country announced a major new financing deal with the International…
Bitcoin has been consolidating within a tight range in recent weeks, amidst fears of Trump tariffs pushing the US…
Wall Street analysts on Monday said pre-buying cars ahead of tariffs will provide a temporary lift to US carmakers…
Technology companies pick China for production primarily because it offers lower labour costs.That’s the widespread conception, or perhaps a…
Webull Corporation (NASDAQ: BULL) investors sure is a happy lot on Monday.The retail-focused investment platform completed its merger with…